SCHEMBL23698417

SCHEMBL23698417

CCCCCCn1cc[n+](-c2c(C)cc(C)cc2C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.51
▸ RAB9A P51151 6/20 0.51
▸ HTT P42858 5/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ HSP90AA1 P07900 3/20 0.51
▸ MAPK1 P28482 3/20 0.51
▸ NPSR1 Q6W5P4 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ APAF1 O14727 1/20 0.51
▸ PLA2G1B P04054 1/20 0.51
▸ ATG4B Q9Y4P1 1/20 0.51
▸ PON1 P27169 1/20 0.42
▸ GALR3 O60755 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ RAD52 P43351 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21834756 1.00 NPC1 (0.51) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
SCHEMBL23698381 1.00 NPC1 (0.51) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
SCHEMBL21834759 1.00 NPC1 (0.51) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
SCHEMBL23698569 1.00 NPC1 (0.51) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
SCHEMBL28544070 1.00 NPC1 (0.51) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
Bromide SCHEMBL1884396 0.98 NPC1 (0.54) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
Bromide SCHEMBL1885380 0.98 NPC1 (0.54) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
Bromide SCHEMBL1879504 0.98 NPC1 (0.54) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
Bromide SCHEMBL1885921 0.98 NPC1 (0.54) NPC1RAB9AHTTSMN1; SMN2HSP90AA1
Bromide SCHEMBL1881356 0.98 NPC1 (0.54) NPC1RAB9AHTTSMN1; SMN2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 — — US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 — — US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 — — EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM NPC1 408/4885RAB9A 1361/4885HTT 1900/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM NPC1 408/4885RAB9A 1361/4885HTT 1900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback